LAP&P’s interactive training on TMDD at PAGE 2025

Dear PAGE participants, We gladly invite you to our one-and-a-half-day course, in which we will discuss the importance of understanding the pharmacology of monoclonal antibodies (mAbs) to make the right decisions in target-mediated drug disposition (TMDD) model development. After a short introduction, where we will directly dive into a hands-on session, we’ll work in small groups on a TMDD modelling project using nlmixr2 within a shinyMixR workflow. LAP&P’s interactive training will be held on Monday the 2nd of June 2025 (13 – 17) and Tuesday the 3rd of June (9-17) in Thessaloniki - Greece. Find more information and register for the course on LAP&P course | https://lapp.nl/lapp-course/ or on the PAGE website under Satellite Meetings. For questions, feel free to reach out to us. Hope to see you there! Tamara van Steeg Tamara van Steeg, PhD LAP&P Consultants Leiden, The Netherlands Web: http://www.lapp.nl/